Tiotropium bromide

Superiority:

product details 
Tiotropium bromide, also known as teutopine bromide, is a new bronchodilator successfully developed by boehringeringelheim company in the Netherlands. It is a long-acting anticholinergic drug. It has selective inhibitory effect on M3 receptor, long maintenance time of blood concentration and small side effects. Tiotropium bromide is equivalent to ipratropium bromide in the treatment of chronic obstructive pulmonary disease (COPD), But its advantage is that it only needs to be administered once a day, while the latter needs to be administered four times a day. Recent studies have shown that long-acting β 2 adrenoceptor agonists (such as formoterol) can also effectively dilate bronchial chemicalbook compared with short acting ones. Both formoterol and tiotropium bromide can significantly increase the first second forced expiratory volume (FEV1), forced vital capacity (FVC) and resting deep inspiratory volume (IC), and the improvement of pulmonary function is more obvious when they are combined than when they are used alone. Tiotropium bromide powder inhaler is a bronchodilator, which is suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including the maintenance treatment of chronic bronchitis and emphysema, concomitant dyspnea and the prevention of acute attack. Tiotropium bromide inhalation powder is prohibited for patients with allergic reactions to tiotropium bromide, atropine or its derivatives, such as ipratropium bromide or oxytropium bromide or lactose, the excipient of this product.
Name of drug or intermediate: tiotropium bromide
CAS No.: 136310-93-5
Molecular formula: c19h22brno4s2
Delivery volume: 100mg 1g 100g 1kg 5kg
Purity: 98% or higher
Delivery standard: sample COA, sample purity HPLC, if necessary, discuss separately
Delivery date: specific communication